Google Chrome
Safari
Firefox
Edge
Press Clipping / May 03, 2023
Hovione and Presspart extend technology partnership
Manufacturing Chemist, 3 May 2023
Search
News / Apr 12, 2021
Guy Villax wins EY Award “Entrepreneur of the Year”
EY Entrepreneur Of The Year is the world's most prestigious business award for entrepreneurs
Press Release / Sep 19, 2024
Hovione and iBET Announce the Establishment of ViSync® Technologies: A Venture in Cell and Gene Therapy Solutions
Commitment to partnership and joint innovation for cell and gene therapies
Press Release / Sep 20, 2019
Hovione announces successful end-of-phase 2 meeting with the FDA and outlines phase 3 program for minocycline topical gel
Hovione announced details of its planned MARS-2 and MARS-3 (Minocycline Against Rosacea Study) Phase 3 development program for the treatment of moderate to severe inflammatory rosacea.
News / Sep 17, 2021
World Patient Safety Day 2021
Safety First, Quality Always: We are continuously improving the safety of our operations with the patient’s safety in mind.
Press Release / Feb 25, 2022
Jean-Luc Herbeaux to become Hovione CEO
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
Press Clipping / Apr 06, 2023
Hovione 2023 CDMO Leadership Awards Winner Interview
Outsourced Pharma, April 2023
News / Sep 09, 2024
Hovione Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions
Hovione commitment to setting SBTs in line with the Paris Agreement